Purpose: To investigate the relationship between total body weight (TB
W) or body mass index (BMI) and atracurium reversal time. Methods: The
study population comprised 25 patients with TBW <80 kg and 25 patient
s with TBW greater than or equal to 80 kg anaesthetised with midazolam
, thiopentone, fentanyl, nitrous oxide and halothane. Neuromuscular bl
ock was induced with 0.5 mg . kg(-1) atracurium and maintained with do
ses of 0.15 mg . kg(-1). Neuromuscular transmission was recorded using
train-of-four (TOF) nerve stimulation and mechanomyography, Neostigmi
ne, 0.07 mg . kg(-1), was administered when the first twitch in TOF ha
d recovered to 10% of control. Reversal time was defined as: time from
administration of neostigmine until TOF ratio recovered to 0.70. Resu
lts: There was no difference in reversal time between patients with TB
W <80 kg (7.2 +/- 2.6 min, mean +/- SD), and patients with TBW greater
than or equal to 80 kg (6.9 +/- 3.6 min). When patients were grouped
according to BMI there was no difference in reversal time between grou
ps with low BMI (6.9 +/- 2.6 min) or high BMI (7.1 +/- 3.6 min), There
was, furthermore, no difference in reversal time between the 15 patie
nts in the study population with the smallest TBW or BMI and the 15 pa
tients with the greatest TBW or BMI, there was no correlation between
TBW or BMI and reversal time, Conclusion: When atracurium-induced neur
omuscular block is antagonised with 0.07 mg . kg(-1) neostigmine, TBW
or BMI have no influence on reversal time.